December 09, 2011
A unit of Valeant Pharmaceuticals International Inc. on Thursday resolved its suit in New York federal court accusing Par Pharmaceutical Cos. Inc. of infringing its patents by seeking to launch a generic version of Valeant's antidepressant Aplenzin.